• β-Amanitin in RNA Polymerase II Transcription Studies: Advan

  2026-06-19

  Discover how β-Amanitin, a potent RNA polymerase II inhibitor, enables high-specificity transcriptional regulation research and mRNA synthesis inhibition assays. This guide provides experimentally grounded protocols, troubleshooting insights, and applied use-cases, integrating recent innovations in rapid toxin detection and comparative workflow strategies.

• Phosbind Acrylamide: Revolutionizing Phosphorylation Detecti

  2026-06-19

  Phos binding reagent (Phosbind) acrylamide empowers researchers to visualize protein phosphorylation directly on SDS-PAGE, bypassing the need for phospho-specific antibodies. Its selectivity and workflow simplicity transform signaling pathway analysis across plant and biomedical research.

• Scenario-Driven Solutions with Cell lysis buffer for WB and

  2026-06-18

  This article provides a scenario-driven, evidence-based exploration of real laboratory challenges in protein extraction, focusing on the performance and reliability of 'Cell lysis buffer for WB and IP' (SKU K1123). By addressing common pain points in Western blot and immunoprecipitation workflows, we highlight how the buffer’s protease and phosphatase inhibitor cocktail ensures data fidelity and reproducibility for biomedical researchers.

• Norovirus Uses NINJ1 for Selective Protein Secretion During

  2026-06-18

  Song et al. reveal that murine norovirus co-opts the host protein NINJ1 to selectively export its NS1 protein during programmed cell death, a process previously thought to cause only indiscriminate cellular content release. This discovery uncovers a new paradigm in unconventional protein secretion and highlights potential intersections between viral pathogenesis, host immunity, and regulated cell death.

• CRTC-CREB Axis Senses Proteotoxic Stress via Proteasome Inhi

  2026-06-17

  This study uncovers how the CRTC-CREB transcriptional axis functions as a sensor of proteotoxic and oxidative stress following proteasome β5 subunit inhibition in Drosophila. The findings elucidate mechanistic links between ROS/JNK signaling, CREB activation, and protein homeostasis, offering new avenues for research into neurodegeneration and cellular stress responses.

• Rifampin: Applied Protocols for Bacterial Transcription Inhi

  2026-06-17

  Rifampin’s precise inhibition of bacterial RNA polymerase makes it indispensable for transcription regulation, resistance mechanism research, and advanced synthetic biology. This article delivers actionable protocol enhancements, troubleshooting strategies, and workflow insights—grounding every step in current data and comparative literature.

• Inhibition of Extracellular Vesicle Release in TNBC: Calpept

  2026-06-16

  McNamee et al. conducted a systematic evaluation of potential inhibitors of extracellular vesicle (EV) release in triple-negative breast cancer (TNBC), identifying that broad suppression of EVs—including with the calpain inhibitor Calpeptin—significantly reduces the transmission of aggressive phenotypes. Their findings suggest that total inhibition of EV release may be necessary to fully block deleterious cell-to-cell communication in TNBC models, providing a foundation for future therapeutic strategies.

• Drug-Sensitized Yeast Unveils mTOR Inhibitors with Enhanced

  2026-06-16

  This study introduces a drug-sensitized yeast platform that increases the sensitivity and efficiency of identifying mTOR inhibitors, critical for aging and cancer research. The findings establish a robust, scalable system for screening candidate compounds, clarifying the selectivity of agents including Nebivolol hydrochloride.

• Anti-Epileptic Drugs Noncompetitively Inhibit Human Serum PO

  2026-06-15

  This study systematically evaluates how common anti-epileptic drugs, including phenytoin (5,5-diphenylimidazolidine-2,4-dione), inhibit human serum paraoxonase-1 (hPON1) activity in vitro. The findings offer quantitative insights into drug-enzyme interactions with implications for understanding metabolic side effects in epilepsy therapy.

• ML133 HCl: Precision Tool for Decoding Kir2.1 in Vascular Re

  2026-06-15

  Explore how ML133 HCl, a selective potassium channel inhibitor, uniquely empowers researchers to dissect Kir2.1’s role in pulmonary artery smooth muscle cell proliferation and vascular remodeling. Gain advanced insights for cardiovascular ion channel research and practical assay design.

• LncRNA FAISL Blocks Calpain 2-Driven FAK Cleavage in TNBC Pr

  2026-06-14

  The reference study uncovers how lncRNA FAISL stabilizes FAK protein by inhibiting calpain 2-mediated proteolysis, thereby promoting the progression and metastasis of triple negative breast cancer (TNBC). These findings clarify a post-translational regulatory mechanism of FAK in TNBC and highlight new avenues for targeted intervention.

• FLAG tag Peptide (DYKDDDDK): Single-Molecule Imaging Frontie

  2026-06-13

  Explore the advanced use of FLAG tag Peptide (DYKDDDDK) as a cornerstone for single-molecule imaging and rapid antibody screening. This in-depth article reveals new workflows and mechanistic insights that go beyond conventional purification, making it essential reading for innovative recombinant protein detection.

• SU 5402: Advancing Kinase Inhibition in Complex Disease Mode

  2026-06-12

  Explore how SU 5402, a potent kinase inhibitor, enables advanced research in cancer biology and beyond. This article delivers rigorous scientific insight, protocol guidance, and fresh analysis distinct from prior reviews.

• Methyl-β-cyclodextrin: Technical Protocols for Membrane Rese

  2026-06-12

  Methyl-β-cyclodextrin (SKU C6939) enables selective extraction of cholesterol and certain lipids from cellular membranes, supporting membrane fluidity modulation and lipid raft disruption studies. This reagent is intended for controlled laboratory research and should not be used in diagnostic or medical applications.

• Intravesical p21 mRNA–LNP Therapy for Bladder Cancer: Advanc

  2026-06-11

  This article explores a recent study that pioneers the localized delivery of p21 mRNA via lipid nanoparticles for bladder cancer. The research demonstrates significant tumor suppression and mechanistic restoration of tumor suppressor function, highlighting the clinical potential of mRNA-based therapies for urothelial malignancies.

14779 records 1/986 page Next 12345 下5页 Last page